MedPath

Effect of High Intensity Interval Training with Blood Flow Restriction on cardiovascular function of Cardiotoxic patients after Breast Cancer therapy

Not Applicable
Conditions
Condition 1: Cardiotoxicity. Condition 2: Cardiac rehabilitation. Condition 3: Breast Cancer.
Cardiomyopathy due to drug and external agent
Malignant neoplasm of breast
Therapeutic (nonsurgical) and rehabilitative cardiovascular devices associated with adverse incidents
I42.7
Y71.1
Registration Number
IRCT20200412047045N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
20
Inclusion Criteria

Breast Cancer patients
Age < 65y
Second phase of rehabilitation
Without Cardiac diseaes before Cancer Treatment
Treatment Drug: Anthracyclines
40 =Ejection Fraction= 50
Heart failure treatment: Beta blockers, ACEI
Permission of Cardiologist
Signature of consent letter

Exclusion Criteria

Conditions that cause the patient, not be able to perform the exercises(Fracture of limbs, pregnancy,…)
Symptoms of severe heart failure
Sign of recurrence of breast cancer (repeat chemotherapy)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiovascular function. Timepoint: before intervention and after 12 weeks after intervention. Method of measurement: echocardiography.
Secondary Outcome Measures
NameTimeMethod
ew York Heart Association (NYHA) Functional Classification. Timepoint: before and after 12 weeks intervention. Method of measurement: the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity.
© Copyright 2025. All Rights Reserved by MedPath